GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sensus Healthcare Inc (NAS:SRTS) » Definitions » EBIT

SRTS (Sensus Healthcare) EBIT : $8.09 Mil (TTM As of Sep. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Sensus Healthcare EBIT?

Sensus Healthcare's earnings before interest and taxes (EBIT) for the three months ended in Sep. 2024 was $1.50 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Sep. 2024 was $8.09 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Sensus Healthcare's annualized ROC % for the quarter that ended in Sep. 2024 was 11.83%. Sensus Healthcare's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was 19.32%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Sensus Healthcare's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was 14.10%.


Sensus Healthcare EBIT Historical Data

The historical data trend for Sensus Healthcare's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sensus Healthcare EBIT Chart

Sensus Healthcare Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -6.82 4.12 14.83 -0.38 8.09

Sensus Healthcare Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.58 2.89 1.98 1.50 1.73

Competitive Comparison of Sensus Healthcare's EBIT

For the Medical Devices subindustry, Sensus Healthcare's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sensus Healthcare's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sensus Healthcare's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Sensus Healthcare's EV-to-EBIT falls into.



Sensus Healthcare EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $8.09 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sensus Healthcare  (NAS:SRTS) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Sensus Healthcare's annualized ROC % for the quarter that ended in Sep. 2024 is calculated as:

ROC % (Q: Sep. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2024 ) + Invested Capital (Q: Sep. 2024 ))/ count )
=5.98 * ( 1 - 31.51% )/( (35.907 + 33.327)/ 2 )
=4.095702/34.617
=11.83 %

where

Note: The Operating Income data used here is four times the quarterly (Sep. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Sensus Healthcare's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Sep. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2024  Q: Sep. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=5.98/( ( (1.391 + max(31.014, 0)) + (2.265 + max(27.238, 0)) )/ 2 )
=5.98/( ( 32.405 + 29.503 )/ 2 )
=5.98/30.954
=19.32 %

where Working Capital is:

Working Capital(Q: Jun. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(18.293 + 12.769 + 4.439) - (3.284 + 0.686 + 0.517)
=31.014

Working Capital(Q: Sep. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(16.961 + 11.968 + 3.319) - (3.973 + 0.686 + 0.351)
=27.238

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Sensus Healthcare's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Sep. 2024 )
=8.09/57.394
=14.10 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sensus Healthcare EBIT Related Terms

Thank you for viewing the detailed overview of Sensus Healthcare's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Sensus Healthcare Business Description

Traded in Other Exchanges
Address
851 Broken Sound Parkway, NW, Suite 215, Boca Raton, FL, USA, 33487
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.
Executives
Michael Sardano officer: GENERAL COUNSEL 851 BROKEN SOUND PARKWAY NW STE. 215, BOCA RATON FL 33487
Javier Rampolla officer: Chief Financial Officer 851 BROKEN SOUND PARKWAY NW STE 215, BOCA RATON FL 33487
John Heinrich director 851 BROKEN SOUND PARKWAY NW, STE. 215, BOCA RATON FL 33487
Joseph C Sardano director, officer: Chief Executive Officer 851 BROKEN SOUND PARKWAY NW, STE. 215, BOCA RATON FL 33487
Samuel O'rear director 851 BROKEN SOUND PARKWAY NW, STE. 215, BOCA RATON FL 33487
Magdalena Martinez officer: Chief Operating Officer 851 BROKEN SOUND PARKWAY NW #215, BOCA RATON FL 33487
Emiliano Sosa officer: Chief Technology Officer 851 BROKEN SOUND PARKWAY NW #215, BOCA RATON FL 33487
William H Mccall director 851 BROKEN SOUND PARKWAY NW STE. 215, BOCA RATON FL 33487
Nicolas Soro officer: Chief Operating Officer 851 BROKEN SOUND PARKWAY NW STE 215, BOCA RATON FL 33487
Stephen Brad Cohen officer: EXECUTIVE VICE PRESIDENT 851 BROKEN SOUND PARKWAY NW, STE. 215, BOCA RATON FL 33487
Megan Cornish director 851 BROKEN SOUND PARKWAY NW #215, BOCA RATON FL 33487
Yonatan Vainer officer: Chief Technology Officer 851 BROKEN SOUND PARKWAY NW #215, BOCA RATON FL 33487
Russ Price officer: Chief Technology Officer 851 BROKEN SOUND PARKWAY NW STE 215, BOCA RATON FL 33487
Kalman Fishman officer: CHIEF TECHNOLOGY OFFICER 851 BROKEN SOUND PARKWAY NW #215, BOCA RATON FL 33487
Richard Golin officer: EXECUTIVE VICE PRESIDENT 851 BROKEN SOUND PARKWAY NW, STE. 215, BOCA RATON FL 33487